These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26807291)

  • 1. Molecular Genetic Testing in Pain and Addiction: Facts, Fiction and Clinical Utility.
    Blum K; Hauser M; Fratantonio J; Badgaiyan RD
    Addict Genet; 2015 Jul; 2(1):1-5. PubMed ID: 26807291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction.
    Blum K; Badgaiyan RD; Agan G; Fratantonio J; Simpatico T; Febo M; Haberstick BC; Smolen A; Gold MS
    J Reward Defic Syndr; 2015; 1(1):65-68. PubMed ID: 26052557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic addiction risk score (GARS) ™, a predictor of vulnerability to opioid dependence.
    Blum K; Chen ALC; Thanos PK; Febo M; Demetrovics Z; Dushaj K; Kovoor A; Baron D; Smith DE; Roy AK; Fried L; Chen TJH; Chapman E; Modestino EJ; Steinberg B; Badgaiyan RD
    Front Biosci (Elite Ed); 2018 Jan; 10(1):175-196. PubMed ID: 28930612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Search of Reward Deficiency Syndrome (RDS)-free Controls: The "Holy Grail" in Genetic Addiction Risk Testing.
    Blum K; Baron D; Lott L; Ponce JV; Siwicki D; Boyett B; Steinberg B; Modestino EJ; Fried L; Hauser M; Simpatico T; Downs BW; McLaughlin T; Hajela R; Badgaiyan RD
    Curr Psychopharmacol; 2020; 9(1):7-21. PubMed ID: 32432025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS).
    Blum K; Oscar-Berman M; Demetrovics Z; Barh D; Gold MS
    Mol Neurobiol; 2014 Dec; 50(3):765-96. PubMed ID: 24878765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms.
    Blum K; Simpatico T; Badgaiyan RD; Demetrovics Z; Fratantonio J; Agan G; Febo M; Gold MS
    J Reward Defic Syndr; 2015; 1(2):75-80. PubMed ID: 27617300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Benefits of Genetic Addiction Risk Score (GARS
    Blum K; Modestino EJ; Gondre-Lewis M; Chapman EJ; Neary J; Siwicki D; Baron D; Hauser M; Smith DE; Roy AK; Thanos PK; Steinberg B; McLaughlin T; Fried L; Barh D; Dunston GA; Badgaiyan RD
    Int J Genom Data Min; 2018; 2018(1):. PubMed ID: 30198022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
    Blum K; Dennen CA; Elman I; Bowirrat A; Thanos PK; Badgaiyan RD; Downs BW; Bagchi D; Baron D; Braverman ER; Gupta A; Green R; McLaughlin T; Barh D; Gold MS
    J Pers Med; 2022 Oct; 12(10):. PubMed ID: 36294858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function of Molecular Neurobiological Mechanisms.
    Blum K; Oscar-Berman M; Stuller E; Miller D; Giordano J; Morse S; McCormick L; Downs WB; Waite RL; Barh D; Neal D; Braverman ER; Lohmann R; Borsten J; Hauser M; Han D; Liu Y; Helman M; Simpatico T
    J Addict Res Ther; 2012 Nov; 3(5):139. PubMed ID: 23926462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery.
    Blum K; Bailey J; Gonzalez AM; Oscar-Berman M; Liu Y; Giordano J; Braverman E; Gold M
    J Genet Syndr Gene Ther; 2011 Dec; 2012(1):. PubMed ID: 23483116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro-Dopamine Regulator (KB220) A Fifty Year Sojourn to Combat Reward Deficiency Syndrome (RDS): Evidence Based Bibliography (Annotated).
    Kenneth B; Edward MJ; Marjorie GLC; David B; Bruce S; Panayotis TK; William DB; Davis S; Lisa L; Eric BR; Mark M; David M; Lyle F; Rajendra BD
    CPQ Neurol Psychol; 2018; 1(2):. PubMed ID: 30957097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute intravenous synaptamine complex variant KB220™ "normalizes" neurological dysregulation in patients during protracted abstinence from alcohol and opiates as observed using quantitative electroencephalographic and genetic analysis for reward polymorphisms: part 1, pilot study with 2 case reports.
    Miller DK; Bowirrat A; Manka M; Miller M; Stokes S; Manka D; Allen C; Gant C; Downs BW; Smolen A; Stevens E; Yeldandi S; Blum K
    Postgrad Med; 2010 Nov; 122(6):188-213. PubMed ID: 21084795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biotechnical development of genetic addiction risk score (GARS) and selective evidence for inclusion of polymorphic allelic risk in substance use disorder (SUD).
    Blum K; Bowirrat A; Baron D; Lott L; Ponce JV; Brewer R; Siwicki D; Boyett B; Gondre-Lewis MC; Smith DE; Panayotis K T; Badgaiyan S; Hauser M; Fried L; A R; Downs BW; Badgaiyan RD
    J Syst Integr Neurosci; 2020 Aug; 6(2):. PubMed ID: 33614164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.
    Blum K; Kazmi S; Modestino EJ; Downs BW; Bagchi D; Baron D; McLaughlin T; Green R; Jalali R; Thanos PK; Elman I; Badgaiyan RD; Bowirrat A; Gold MS
    J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33809702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family.
    Dennen CA; Blum K; Bowirrat A; Thanos PK; Elman I; Ceccanti M; Badgaiyan RD; McLaughlin T; Gupta A; Bajaj A; Baron D; Downs BW; Bagchi D; Gold MS
    J Pers Med; 2022 Nov; 12(11):. PubMed ID: 36579592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "TO BE OR NOT TO BE" GWAS Ends the Controversy about the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS).
    Blum K; Thanos PK; Hanna C; Gold MS; Baron D; Elman I
    Psychol Res Behav Manag; 2023; 16():4287-4291. PubMed ID: 37885829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management".
    Blum K; Steinberg B; Gondre-Lewis MC; Baron D; Modestino EJ; Badgaiyan RD; Downs BW; Bagchi D; Brewer R; McLaughlin T; Bowirrat A; Gold M
    Psychol Res Behav Manag; 2021; 14():2115-2134. PubMed ID: 34949945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?
    Blum K; McLaughlin T; Bowirrat A; Modestino EJ; Baron D; Gomez LL; Ceccanti M; Braverman ER; Thanos PK; Cadet JL; Elman I; Badgaiyan RD; Jalali R; Green R; Simpatico TA; Gupta A; Gold MS
    J Pers Med; 2022 Feb; 12(2):. PubMed ID: 35207809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine Genetics and Function in Food and Substance Abuse.
    Blum K; Oscar-Berman M; Barh D; Giordano J; Gold M
    J Genet Syndr Gene Ther; 2013 Feb; 4(121):. PubMed ID: 23543775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for the
    Blum K; Bowirrat A; Elman I; Baron D; Thanos PK; Gold MS; Hanna C; Makale MT; Sunder K; Jafari N; Zeine F; Murphy KT; Makale M; Badgaiyan RD
    Clin Exp Psychol; 2023 Jun; 9(4):8-11. PubMed ID: 37560184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.